Excipient lung disease in a patient taking the benzodiazepine derivative etizolam: A case report

Excipient Lung Disease is an inflammatory response to the intravenous administration of oral formulations of drugs and their excipients (additives). Previously described offenders include opioids and Ritalin, whose excipients, when crushed and administered intravenously, lead to inflammation and are...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Ben C, Grant, Thomas, Allen, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818925/
https://www.ncbi.nlm.nih.gov/pubmed/35145565
http://dx.doi.org/10.1016/j.radcr.2022.01.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818925/
https://www.ncbi.nlm.nih.gov/pubmed/35145565
http://dx.doi.org/10.1016/j.radcr.2022.01.035

Ejemplares similares